LXEO
#3166
Lexeo Therapeutics, Inc. - Common Stock
4.6 5 USD
-0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.53%
Monthly Change
+2.65%
6 month change
-40.00%
Year Change
+3.33%
Previous Close
4.8 2
Open
4.6 5
Low
4.6 5
High
4.6 5
Volume
77
Financials
- Market Capitalization 365.13 M
- Employee 59
- Founded 2017
- CEO N/A
- Website www.lexeotx.com
- Headquarter New York, United States
- FIGI BBG00YB1C8M5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3133 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 4.74 USD | -5.01% | -3.27% | +6.28% | +47.66% | 379.33 M USD | ||
| 3147 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.75 USD | +2.48% | -0.46% | +18.78% | +21.47% | 373.42 M USD | ||
| 3181 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 6.00 USD | -3.85% | -4.46% | +1.18% | +8.50% | 360.81 M USD | ||
| 3198 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 4.44 USD | -7.69% | -11.55% | -3.48% | +448.15% | 353.63 M USD |
Frequently asked questions about Lexeo Therapeutics, Inc. - Common Stock
What is the Lexeo Therapeutics, Inc. - Common Stock stock price today?
The current price of Lexeo Therapeutics, Inc. - Common Stock (LXEO) is 4.65. Over the past 24 hours, the stock has changed by -3.53%. Follow the LXEO chart for real-time price dynamics.
What is the stock ticker of Lexeo Therapeutics, Inc. - Common Stock?
Lexeo Therapeutics, Inc. - Common Stock trades under the ticker LXEO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Lexeo Therapeutics, Inc. - Common Stock stock going up?
LXEO has changed by -1.06% over the last week, +2.65% over the last month, and +3.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Lexeo Therapeutics, Inc. - Common Stock net income for the last quarter?
Lexeo Therapeutics, Inc. - Common Stock reported net income of -20.2 M for the last quarter. The previous quarter showed -20.92 M, which means net income changed by +3.46%.
How many employees does Lexeo Therapeutics, Inc. - Common Stock have?
As of the latest available data, Lexeo Therapeutics, Inc. - Common Stock has 59 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Lexeo Therapeutics, Inc. - Common Stock stock?
You can buy Lexeo Therapeutics, Inc. - Common Stock (LXEO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Lexeo Therapeutics, Inc. - Common Stock stock?
Investing in Lexeo Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LXEO chart and related analysis on metatrader.com as part of your research.